Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Obstet Gynecol. 2016 Mar;127(3):426–436. doi: 10.1097/AOG.0000000000001246

Table 2.

Research gaps and opportunities

Area Maternal Topics Neonatal Topics
Prevention of infection Yes Yes
Prediction of infection Yes
Colonization versus infection
Yes
Scoring system for probability of sepsis; infection prediction models to guide clinical management Yes, placental histology, microbiome Yes – need to define by GA, microbiome
Isolated fever in labor Management – antipyretics, NSAIDs, antimicrobial agents Management evaluation and antimicrobial agents
Biomarkers Prediction, Consensus for design of biomarker validation studies and/or reporting of accuracy Prediction, guidance for management, consensus for design of biomarker validation studies or reporting of accuracy
Outcomes In hospital; subsequent reproductive outcomes In-hospital, morbidities; longer term outcomes including neurodevelopment
Antimicrobial agents Timing, duration, selection of antimicrobial agents used Timing, duration, selection of antimicrobial agents used
Post-partum events Fever, clinical course and its relationship to newborn’s care and management
“Epidural fever” investigation Management and treatment Management and treatment
Maternal Fever Timing, duration, height and impact on clinical care and course Timing, duration, height and impact on clinical care and course
Duration of antimicrobial therapy Timing and selection of antimicrobial agents Term infant- well appearing-Term infant –symptomatic Term infant – resolved minor symptoms
Preterm infant
Link studies – mother and baby cohorts Impact of infection on neurodevelopment impairment or CP
Observation versus treatment Low risk cohorts
Corticosteroids Effects –short and long term Effects prenatal and post-natal
Microbiome – maternal-fetal microbiome ecosystem Perturbations, influence of GI flora on GU flora Symbiosis versus pathology